American Clinical Research Services’ Post

Latticework Capital Management is proud to announce American Clinical Research Services' strategic acquisition of Elixia Founded in 2019 by Neal Patel and Jim Crissy, Elixia has rapidly ascended to become a leading clinical trial site network in trials involving specialty patient populations, particularly in nephrology. Building on this foundation, Elixia extended its expertise to encompass neurosciences and infectious diseases, further cementing its reputation in these critical and complex areas of medicine. Dustin Owen, CEO of ACRS, stated, "The integration of Elixia not only broadens our capabilities in nephrology but also enhances our collective expertise in neuroscience and allows us to multiply our sites capable of conducting complex metabolic indications. Elixia’s presence in multiple states enhances our ability to access a diverse range of participants across the nation, beyond our current footprint of Southern California and Texas, enriching the breadth and depth of our research endeavors." Click here to learn more: https://lnkd.in/g_dgvfFP #privateequity #mergersandacquisitions #clinicalresearch #clinicaltrials